Developer docs
API playgroundTry for free, no card

Search company profiles

Nutricia

Full company profile

uuid000898n

Namestring
Nutricia
Legal namestring
Nutricia International B.V.
Websiteurl
nutricia.com
Company typeenum
Private
Founded yearint
1896
Descriptiontext

Nutricia, founded in 1896 in the Netherlands and headquartered in Hoofddorp, is a specialized medical nutrition company operating as a wholly-owned brand within Danone S.A.'s Specialized Nutrition division. The company develops, manufactures, and markets prescription Foods for Special Medical Purposes (FSMP) across 13 therapeutic areas spanning the full lifecycle—from preterm infant formula (Nutrilon, Nutriprem), extensively hydrolyzed and amino acid-based formulas for cow's milk allergy (Aptamil Pepti, Neocate with the proprietary Syneo blend), and inherited metabolic disorder products (Anamix, Lophlex, Loprofin for PKU, MSUD, Tyrosinemia, GA1), through to disease-related malnutrition supplements (Fortimel range), oncology nutrition (Forticare, Calogen), epilepsy management (Ketocal), stroke and dysphagia products (Nutilis), wound care (Cubitan), early Alzheimer's support (Souvenaid), and enteral tube feeding (Nutrison, Flocare pumps). The portfolio is anchored by proprietary innovations including the Syneo blend of oligosaccharide fibers and Bifidobacterium breve, the 1995 intestinal simulation model, and high-quality plant-based protein formulations achieving a PDCAAS score of 1, supported by R&D at the Utrecht Science Park facility.

The business operates on a prescription-driven model where products are prescribed by healthcare professionals and dispensed through hospitals, clinics, and pharmacies in over 100 countries. Revenue is generated primarily through the sale of specialized medical nutrition products (oral nutritional supplements, enteral formulas, and medical devices), with distribution via healthcare professional prescription channels, direct hospital/clinical supply, and local market distribution networks. Manufacturing is concentrated at purpose-built sustainable plants in Cuijk (Netherlands, opened 2019, €240M investment) and Opole (Poland, new medical nutrition line opened 2024). Pricing is not publicly disclosed, consistent with the prescribed, medically-supervised FSMP distribution model.

Go-to-market is built around healthcare professional engagement through medical congresses (ESPEN, ESPGHAN, ESMO), education platforms (Danone Nutricia Campus launched 2023, Nutricia Education), clinical evidence publication, and field sales targeting hospital systems globally. The company also pursues digital channel expansion through its January 2024 partnership with National Resilience, Inc. for a digital oncology platform.

Short descriptiontext

Nutricia, founded in 1896 and part of Danone, develops prescription medical nutrition products (FSMP) across 13 therapeutic areas. The Netherlands-based company serves patients in 100+ countries, spanning preterm infants with cow's milk allergy to elderly cancer patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHoofddorp, Netherlands
HQ citystring
Hoofddorp
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical nutrition, specialized nutrition, disease-related malnutrition, infant formula, enteral feeding
Industry4 codes
1Medical Foods Manufacturing (Disease-Specific, Clinically Supervised)
CodeAFAKAJACPrimaryYes
2Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled)
CodeCRADAEAOPrimaryNo
3Functional Senior Nutrition Foods Manufacturing (High-Protein, Bone/Joint Support Foods)
CodeAFAKAJAKPrimaryNo
4Functional Baby & Kids Foods Manufacturing (Fortified Infant/Toddler Foods, Kids Nutrition)
CodeAFAKAJAJPrimaryNo
NAICS code3 codes
  • Food Manufacturing311
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
  • Frozen Specialty Food Manufacturing311412
SIC code3 codes
  • Food And Kindred Products2000
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Medical Nutrition
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Specialized Medical Nutrition Products
TypeOthers
Description

Nutricia generates revenue through the sale of specialized medical nutrition products including oral nutritional supplements, tube feeding products, and disease-specific formulations. Products are classified as Foods for Special Medical Purposes (FSMP) and sold through healthcare professional prescriptions and medical supervision channels.

nutricia.com
2Infant Nutrition Products
TypeOne Time License
Description

Sale of infant formula and nutritional products for infants with special dietary needs, including preterm infants, cow's milk allergy formulas, and inherited metabolic disorder formulas.

fortunebusinessinsights.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 19 records shown
1Fortimel
Description

Range of oral nutritional supplements (ONS) for disease-related malnutrition, including Fortimel Compact Protein, Fortimel PlantBased Protein, Fortimel Energy, and Fortimel Advanced

nutricia.com
+18 more records
Core offering1 text field

Nutricia manufactures and sells specialized medical nutrition products classified as Foods for Special Medical Purposes (FSMP), including oral nutritional supplements (Fortimel), enteral/tube feeding formulas (Nutrison), preterm and allergy infant formulas (Nutrilon, Neocate, Aptamil Pepti), ketogenic formulas (Ketocal), inherited metabolic disorder products (Anamix, Lophlex, Loprofin), and condition-specific nutrition for oncology, frailty, stroke/dysphagia, wound care, and early Alzheimer's. Products are prescribed by healthcare professionals and dispensed through hospitals, clinics, and pharmacies across more than 100 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 95% of patients adhered to Fortimel PlantBased Protein prescription in clinical study, compared to typical 20% discontinuation rate due to flavor fatigue
+7 more records
Product overview1 text field

Nutricia offers a comprehensive portfolio of medical nutrition products and specialized nutritional solutions designed for specific disease conditions and life stages. The portfolio operates as a platform-plus-modules architecture centered around medical nutrition for disease-related malnutrition (DRM), with distinct product lines spanning: (1) Fortimel oral nutritional supplements (ONS) including Fortimel PlantBased Protein/Energy for plant-based options and Fortimel Compact formats; (2) Nutrison tube feeding range including the reformulated plant-based variant; (3) Disease-specific solutions including Ketocal for epilepsy, Aptamil Pepti and Neocate for cow's milk allergy, Anamix/Lophlex/Loprofin for inherited metabolic disorders (PKU, MSUD, Tyrosinemia, GA1); (4) Early life nutrition (Nutrilon preterm products, Profutura, Sensavia, Nutriprem); (5) Oncology nutrition (Forticare, Calogen, Fortimel oncology-specific products); (6) Frailty and sarcopenia support (Fortimel range, Fortifit, Protifar); (7) Pediatric DRM (Infatrini, Nutrini); (8) Wound care (Cubitan, Advanced Cubison); (9) Stroke and dysphagia (Nutilis range); (10) Alzheimer's (Souvenaid); supported by enteral feeding devices (Flocare Infinity pump). The portfolio is complemented by educational platforms including Danone Nutricia Campus and Nutricia Education for healthcare professional development.

Product and service19 records
1Fortimel Range (Oral Nutritional Supplements)
CategoryOral Nutritional Supplements
Description

Comprehensive range of oral nutritional supplements (ONS) for disease-related malnutrition, including Fortimel Compact Protein, Fortimel 2kcal, Fortimel Compact Energy, Fortimel Advanced, Fortimel Yoghurt, Fortimel Compact Fibre, Fortimel Peptide, Fortimel Powder, Fortimel Creme 2kcal, Fortimel Energy, Fortimel Jucy, Fortimel Diacare. Available in multiple formats including milkshake, yoghurt, juice, dessert, and powder styles with various protein and energy concentrations.

2Fortimel PlantBased Protein
CategoryPlant-Based Oral Nutritional Supplements
Description

High-protein, high-energy plant-based medical nutrition drink designed for patients with disease-related malnutrition, with savory and sweet flavor options including Pea Mint, Pumpkin Carrot, Pineapple Coconut, and Cappuccino. Demonstrates 45% lower carbon footprint vs standard alternatives.

3Fortimel PlantBased Energy
CategoryPlant-Based Oral Nutritional Supplements
Description

First plant-based ready-to-drink oral nutritional supplement made with high-quality pea and soy protein blend. Provides complete nutrition for malnourished or at-risk-of-malnutrition patients supporting vegan, vegetarian, and flexitarian dietary preferences.

4Nutrison Range (Tube Feeding Formulas)
CategoryEnteral / Tube Feeding Nutrition
Description

Tube feeding formulas for enteral nutrition including Nutrison Energy Multi Fibre, Nutrison Energy, Nutrison Multi Fibre, Nutrison Protein Intense, and Nutrison PlantBased 2kcal High Protein Multi-Fibre. Reformulated with increased plant-based protein content.

5Nutrilon (Preterm Nutrition: Human Milk Fortifier and Protein Supplement)
CategoryPreterm Infant Nutrition
Description

Preterm infant nutrition products including human milk fortifier and protein supplement designed to support growth of premature infants.

6Nutriprem
CategoryPreterm Infant Nutrition
Description

Specialized preterm infant formula designed for the nutritional needs of premature babies.

7Ketocal (3:1, 4:1, 4:1LQ)
CategoryEpilepsy / Ketogenic Medical Nutrition
Description

Ketogenic diet formulas for epilepsy management with different ratios of fats to proteins and carbohydrates. Used for dietary treatment of drug-resistant epilepsy.

8Anamix, Lophlex, Loprofin, Milupa (Inherited Metabolic Disorders)
CategoryInherited Metabolic Disorders Nutrition
Description

Specialized metabolic formulas for inherited metabolic disorders (IMDs/IEM) including PKU (Phenylketonuria), MSUD (Maple Syrup Urine Disease), Tyrosinemia, and GA1 (Glutaric Acidemia Type 1).

9Neocate (Syneo, Junior, LCP, Spoon)
CategoryHypoallergenic Infant Formula
Description

Amino acid-based formulas for infants and children with cow's milk allergy and multiple food allergies. Includes Syneo variant with prebiotic oligosaccharides and probiotic Bifidobacterium breve.

10Aptamil Pepti, Pepti-Junior, Pepti-Syneo
CategoryHypoallergenic Infant Formula
Description

Extensively hydrolyzed formulas for cow's milk allergy in infants, with Pepti-Syneo including Syneo blend of prebiotic fibers and probiotics.

11Souvenaid
CategoryNeurology Medical Nutrition
Description

Medical nutrition drink for early Alzheimer's disease, designed to support cognitive function in patients with mild Alzheimer's.

12Infatrini, Nutrini, NutriniDrink
CategoryPediatric Disease-Related Malnutrition Nutrition
Description

Pediatric disease-related malnutrition nutritional products including high-energy formulas for infants and young children with growth faltering.

13Cubitan, Advanced Cubison
CategoryWound Care Medical Nutrition
Description

Nutritional supplements designed for wound care, providing protein and specific nutrients to support wound healing.

14Nutilis Range (Clear, Complete, Powder, Aqua)
CategoryDysphagia / Texture-Modified Nutrition
Description

Thickened drinks and food textures for stroke and dysphagia patients, compliant with IDDSI framework standards.

15Forticare, Calogen
CategoryOncology Medical Nutrition
Description

Oncology-specific nutritional supplements including Calogen (energy drink) and Forticare for cancer-related malnutrition and cachexia support.

16Flocare Infinity Pump
CategoryEnteral Feeding Medical Device
Description

Enteral feeding pump for reliable and accurate tube feeding delivery, used across oncology and critical care product ranges.

17Profutura, Sensavia (First 1000 Days)
CategoryEarly Life Nutrition
Description

Early life nutrition products for pregnant mothers and infants, part of the First 1000 Days specialization.

18Fortifit Powder, Protifar, Renilon 7.5, Respifor
CategoryFrailty / Disease-Related Malnutrition Supplements
Description

Protein and energy supplements for frailty and disease-related malnutrition including protein powders and high-calorie supplements.

19Probiotic Supplement for Pregnant and Breastfeeding Mothers (Mastitis Prevention)
CategoryMaternal Probiotic Supplement
Description

Probiotic supplement for pregnant and breastfeeding mothers, supported by research showing nearly 60% reduction in mastitis incidence when taken during late pregnancy and early breastfeeding.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Danone S.A. partnered with National Resilience, Inc. in January 2024 to integrate nutrition support into a digital oncology platform. This strategic initiative aims to combine digital health technology with nutritional interventions for cancer patients, aligning with Nutricia's focus on oncology nutrition and patient support solutions.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Abbott's nutrition division offers Ensure, PediaSure, Similac, and a broad medical/clinical nutrition portfolio spanning infant, adult, and disease-specific categories. Directly comparable as a global medical nutrition incumbent selling through hospitals, pharmacies, and healthcare professionals.

TypeDirect peer
Description

Nestlé Health Science competes head-to-head with Nutricia in medical nutrition (Peptamen, Impact, Modulen) and inherited metabolic disorders. Operates the same FSMP/medical-channel model with global hospital and pharmacy distribution.

TypeDirect peer
Description

Fresenius Kabi is a global leader in clinical nutrition (enteral and parenteral), infusion therapy, and IV drugs. Highly comparable to Nutricia's Nutrison and Flocare lines in enteral feeding, with deep hospital procurement relationships.

TypeDirect peer
Description

Mead Johnson, owned by Reckitt, specializes in infant and child nutrition (Enfamil, Nutramigen) including hypoallergenic formulas for cow's milk allergy. Direct overlap with Nutricia's Neocate, Aptamil Pepti, and early-life portfolio.

TypeDirect peer
Description

Baxter's Clinical Nutrition business (formerly part of Baxter) supplies enteral formulas, IV nutrition, and premixed drugs. Comparable through its hospital-focused nutrition portfolio and clinical sales infrastructure.

TypeBroad incumbent
Description

Danone is Nutricia's parent company and operates a broader specialized nutrition, dairy, and plant-based foods portfolio. Relevant as the corporate parent but not directly comparable given its much wider scope beyond medical nutrition.

TypeDirect peer
Description

Hero Group produces infant nutrition (Hero Baby), adult nutrition, and specialty medical nutrition products across European and emerging markets. Compares to Nutricia's early-life and disease-related malnutrition offerings.

TypeEmerging player
Description

Kate Farms is a US-based plant-based enteral and oral medical nutrition company with formulas for pediatric and adult malnutrition. Overlaps with Nutricia's Fortimel PlantBased and Nutrison PlantBased 2kcal in the plant-based medical nutrition niche.

TypeBroad incumbent
Description

Perrigo operates a broad consumer self-care and nutrition platform, including infant formula (store brands) and specialty nutrition. Partial overlap with Nutricia's early-life nutrition and self-pay nutrition categories, though less focused on FSMP prescription channels.

TypeRegional player
Description

HiPP is a family-owned European leader in organic infant nutrition and complementary baby foods. Comparable to Nutricia's infant formula and first 1000 days portfolio, but primarily competes in European organic-leaning segments rather than FSMP medical nutrition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment13 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nutricia

Medical Nutritionnutricia.com

Nutricia, founded in 1896 and part of Danone, develops prescription medical nutrition products (FSMP) across 13 therapeutic areas. The Netherlands-based company serves patients in 100+ countries, spanning preterm infants with cow's milk allergy to elderly cancer patients.

What Nutricia does

Nutricia, founded in 1896 in the Netherlands and headquartered in Hoofddorp, is a specialized medical nutrition company operating as a wholly-owned brand within Danone S.A.'s Specialized Nutrition division. The company develops, manufactures, and markets prescription Foods for Special Medical Purposes (FSMP) across 13 therapeutic areas spanning the full lifecycle—from preterm infant formula (Nutrilon, Nutriprem), extensively hydrolyzed and amino acid-based formulas for cow's milk allergy (Aptamil Pepti, Neocate with the proprietary Syneo blend), and inherited metabolic disorder products (Anamix, Lophlex, Loprofin for PKU, MSUD, Tyrosinemia, GA1), through to disease-related malnutrition supplements (Fortimel range), oncology nutrition (Forticare, Calogen), epilepsy management (Ketocal), stroke and dysphagia products (Nutilis), wound care (Cubitan), early Alzheimer's support (Souvenaid), and enteral tube feeding (Nutrison, Flocare pumps). The portfolio is anchored by proprietary innovations including the Syneo blend of oligosaccharide fibers and Bifidobacterium breve, the 1995 intestinal simulation model, and high-quality plant-based protein formulations achieving a PDCAAS score of 1, supported by R&D at the Utrecht Science Park facility.

The business operates on a prescription-driven model where products are prescribed by healthcare professionals and dispensed through hospitals, clinics, and pharmacies in over 100 countries. Revenue is generated primarily through the sale of specialized medical nutrition products (oral nutritional supplements, enteral formulas, and medical devices), with distribution via healthcare professional prescription channels, direct hospital/clinical supply, and local market distribution networks. Manufacturing is concentrated at purpose-built sustainable plants in Cuijk (Netherlands, opened 2019, €240M investment) and Opole (Poland, new medical nutrition line opened 2024). Pricing is not publicly disclosed, consistent with the prescribed, medically-supervised FSMP distribution model.

Go-to-market is built around healthcare professional engagement through medical congresses (ESPEN, ESPGHAN, ESMO), education platforms (Danone Nutricia Campus launched 2023, Nutricia Education), clinical evidence publication, and field sales targeting hospital systems globally. The company also pursues digital channel expansion through its January 2024 partnership with National Resilience, Inc. for a digital oncology platform.

Nutricia firmographics

Firmographics
Name
Nutricia
Legal name
Nutricia International B.V.
Website
https://nutricia.com
Company type
Private
Founded year
1896
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Nutricia, founded in 1896 and part of Danone, develops prescription medical nutrition products (FSMP) across 13 therapeutic areas. The Netherlands-based company serves patients in 100+ countries, spanning preterm infants with cow's milk allergy to elderly cancer patients.
Ownership category
akta.pro rank

Nutricia industry classification

Industry
Product category
Medical Nutrition
NAICS
Food Manufacturing (311), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Frozen Specialty Food Manufacturing (311412)
SIC
Food And Kindred Products (2000), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro primary industry
Medical Foods Manufacturing (Disease-Specific, Clinically Supervised) (AFAKAJAC)
akta.pro secondary industries
Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled) (CRADAEAO), Functional Senior Nutrition Foods Manufacturing (High-Protein, Bone/Joint Support Foods) (AFAKAJAK), Functional Baby & Kids Foods Manufacturing (Fortified Infant/Toddler Foods, Kids Nutrition) (AFAKAJAJ)

Keywords

  • Medical nutrition
  • Specialized nutrition
  • Disease-related malnutrition
  • Infant formula
  • Enteral feeding

Where Nutricia is headquartered

Location

Headquarters

HQ city
Hoofddorp
HQ country
Netherlands
HQ region
Europe

Offices4 records

Markets served

Nutricia business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Specialized Medical Nutrition Products: Nutricia generates revenue through the sale of specialized medical nutrition products including oral nutritional supplements, tube feeding products, and disease-specific formulations. Products are classified as Foods for Special Medical Purposes (FSMP) and sold through healthcare professional prescriptions and medical supervision channels.
  2. Infant Nutrition Products: Sale of infant formula and nutritional products for infants with special dietary needs, including preterm infants, cow's milk allergy formulas, and inherited metabolic disorder formulas.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Nutricia product offering

Product offering

Core offering

Nutricia manufactures and sells specialized medical nutrition products classified as Foods for Special Medical Purposes (FSMP), including oral nutritional supplements (Fortimel), enteral/tube feeding formulas (Nutrison), preterm and allergy infant formulas (Nutrilon, Neocate, Aptamil Pepti), ketogenic formulas (Ketocal), inherited metabolic disorder products (Anamix, Lophlex, Loprofin), and condition-specific nutrition for oncology, frailty, stroke/dysphagia, wound care, and early Alzheimer's. Products are prescribed by healthcare professionals and dispensed through hospitals, clinics, and pharmacies across more than 100 countries.

Product overview

Nutricia offers a comprehensive portfolio of medical nutrition products and specialized nutritional solutions designed for specific disease conditions and life stages. The portfolio operates as a platform-plus-modules architecture centered around medical nutrition for disease-related malnutrition (DRM), with distinct product lines spanning: (1) Fortimel oral nutritional supplements (ONS) including Fortimel PlantBased Protein/Energy for plant-based options and Fortimel Compact formats; (2) Nutrison tube feeding range including the reformulated plant-based variant; (3) Disease-specific solutions including Ketocal for epilepsy, Aptamil Pepti and Neocate for cow's milk allergy, Anamix/Lophlex/Loprofin for inherited metabolic disorders (PKU, MSUD, Tyrosinemia, GA1); (4) Early life nutrition (Nutrilon preterm products, Profutura, Sensavia, Nutriprem); (5) Oncology nutrition (Forticare, Calogen, Fortimel oncology-specific products); (6) Frailty and sarcopenia support (Fortimel range, Fortifit, Protifar); (7) Pediatric DRM (Infatrini, Nutrini); (8) Wound care (Cubitan, Advanced Cubison); (9) Stroke and dysphagia (Nutilis range); (10) Alzheimer's (Souvenaid); supported by enteral feeding devices (Flocare Infinity pump). The portfolio is complemented by educational platforms including Danone Nutricia Campus and Nutricia Education for healthcare professional development.

Differentiator

Problem solved

Functional benefit

Brands

  • Fortimel: Range of oral nutritional supplements (ONS) for disease-related malnutrition, including Fortimel Compact Protein, Fortimel PlantBased Protein, Fortimel Energy, and Fortimel Advanced
  • Nutrison
  • Aptamil
  • Neocate
  • Ketocal
  • Souvenaid
  • Cubitan
  • Nutilis
  • Milupa
  • Lophlex
  • Loprofin
  • Anamix
  • Infatrini
  • Nutrilon
  • Nutriprem
  • Flocare
  • Danone Nutricia Campus
  • Nutricia Research
  • Cow & Gate

Products and services

  • Fortimel Range (Oral Nutritional Supplements) Comprehensive range of oral nutritional supplements (ONS) for disease-related malnutrition, including Fortimel Compact Protein, Fortimel 2kcal, Fortimel Compact Energy, Fortimel Advanced, Fortimel Yoghurt, Fortimel Compact Fibre, Fortimel Peptide, Fortimel Powder, Fortimel Creme 2kcal, Fortimel Energy, Fortimel Jucy, Fortimel Diacare. Available in multiple formats including milkshake, yoghurt, juice, dessert, and powder styles with various protein and energy concentrations.
  • Fortimel PlantBased Protein High-protein, high-energy plant-based medical nutrition drink designed for patients with disease-related malnutrition, with savory and sweet flavor options including Pea Mint, Pumpkin Carrot, Pineapple Coconut, and Cappuccino. Demonstrates 45% lower carbon footprint vs standard alternatives.
  • Fortimel PlantBased Energy First plant-based ready-to-drink oral nutritional supplement made with high-quality pea and soy protein blend. Provides complete nutrition for malnourished or at-risk-of-malnutrition patients supporting vegan, vegetarian, and flexitarian dietary preferences.
  • Nutrison Range (Tube Feeding Formulas) Tube feeding formulas for enteral nutrition including Nutrison Energy Multi Fibre, Nutrison Energy, Nutrison Multi Fibre, Nutrison Protein Intense, and Nutrison PlantBased 2kcal High Protein Multi-Fibre. Reformulated with increased plant-based protein content.
  • Nutrilon (Preterm Nutrition: Human Milk Fortifier and Protein Supplement) Preterm infant nutrition products including human milk fortifier and protein supplement designed to support growth of premature infants.
  • Nutriprem Specialized preterm infant formula designed for the nutritional needs of premature babies.
  • Ketocal (3:1, 4:1, 4:1LQ) Ketogenic diet formulas for epilepsy management with different ratios of fats to proteins and carbohydrates. Used for dietary treatment of drug-resistant epilepsy.
  • Anamix, Lophlex, Loprofin, Milupa (Inherited Metabolic Disorders) Specialized metabolic formulas for inherited metabolic disorders (IMDs/IEM) including PKU (Phenylketonuria), MSUD (Maple Syrup Urine Disease), Tyrosinemia, and GA1 (Glutaric Acidemia Type 1).
  • Neocate (Syneo, Junior, LCP, Spoon) Amino acid-based formulas for infants and children with cow's milk allergy and multiple food allergies. Includes Syneo variant with prebiotic oligosaccharides and probiotic Bifidobacterium breve.
  • Aptamil Pepti, Pepti-Junior, Pepti-Syneo Extensively hydrolyzed formulas for cow's milk allergy in infants, with Pepti-Syneo including Syneo blend of prebiotic fibers and probiotics.
  • Souvenaid Medical nutrition drink for early Alzheimer's disease, designed to support cognitive function in patients with mild Alzheimer's.
  • Infatrini, Nutrini, NutriniDrink Pediatric disease-related malnutrition nutritional products including high-energy formulas for infants and young children with growth faltering.
  • Cubitan, Advanced Cubison Nutritional supplements designed for wound care, providing protein and specific nutrients to support wound healing.
  • Nutilis Range (Clear, Complete, Powder, Aqua) Thickened drinks and food textures for stroke and dysphagia patients, compliant with IDDSI framework standards.
  • Forticare, Calogen Oncology-specific nutritional supplements including Calogen (energy drink) and Forticare for cancer-related malnutrition and cachexia support.
  • Flocare Infinity Pump Enteral feeding pump for reliable and accurate tube feeding delivery, used across oncology and critical care product ranges.
  • Profutura, Sensavia (First 1000 Days) Early life nutrition products for pregnant mothers and infants, part of the First 1000 Days specialization.
  • Fortifit Powder, Protifar, Renilon 7.5, Respifor Protein and energy supplements for frailty and disease-related malnutrition including protein powders and high-calorie supplements.
  • Probiotic Supplement for Pregnant and Breastfeeding Mothers (Mastitis Prevention) Probiotic supplement for pregnant and breastfeeding mothers, supported by research showing nearly 60% reduction in mastitis incidence when taken during late pregnancy and early breastfeeding.

Quantifiable outcome

  • 95% of patients adhered to Fortimel PlantBased Protein prescription in clinical study, compared to typical 20% discontinuation rate due to flavor fatigue
  • +7 more outcomes

Companies that use Nutricia

Customer profile

Named customers2 records

Segments13 records

Ideal customer profiles2 records

Nutricia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Nutricia partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • National Resilience, Inc.coreStrategic or Co-development Partner · 1 January 2024Danone S.A. partnered with National Resilience, Inc. in January 2024 to integrate nutrition support into a digital oncology platform. This strategic initiative aims to combine digital health technology with nutritional interventions for cancer patients, aligning with Nutricia's focus on oncology nutrition and patient support solutions.

Scale indicators7 records

Recent moves8 records

Expansion highlights4 records

Nutricia competitors and assessment

Company assessment

Direct peers

  • Abbott Nutrition: Abbott's nutrition division offers Ensure, PediaSure, Similac, and a broad medical/clinical nutrition portfolio spanning infant, adult, and disease-specific categories. Directly comparable as a global medical nutrition incumbent selling through hospitals, pharmacies, and healthcare professionals.
  • Nestlé Health Science: Nestlé Health Science competes head-to-head with Nutricia in medical nutrition (Peptamen, Impact, Modulen) and inherited metabolic disorders. Operates the same FSMP/medical-channel model with global hospital and pharmacy distribution.
  • Fresenius Kabi: Fresenius Kabi is a global leader in clinical nutrition (enteral and parenteral), infusion therapy, and IV drugs. Highly comparable to Nutricia's Nutrison and Flocare lines in enteral feeding, with deep hospital procurement relationships.
  • Mead Johnson Nutrition (Reckitt): Mead Johnson, owned by Reckitt, specializes in infant and child nutrition (Enfamil, Nutramigen) including hypoallergenic formulas for cow's milk allergy. Direct overlap with Nutricia's Neocate, Aptamil Pepti, and early-life portfolio.
  • Baxter International: Baxter's Clinical Nutrition business (formerly part of Baxter) supplies enteral formulas, IV nutrition, and premixed drugs. Comparable through its hospital-focused nutrition portfolio and clinical sales infrastructure.
  • Hero Group: Hero Group produces infant nutrition (Hero Baby), adult nutrition, and specialty medical nutrition products across European and emerging markets. Compares to Nutricia's early-life and disease-related malnutrition offerings.

Broad incumbents

  • Danone: Danone is Nutricia's parent company and operates a broader specialized nutrition, dairy, and plant-based foods portfolio. Relevant as the corporate parent but not directly comparable given its much wider scope beyond medical nutrition.
  • Perrigo Company: Perrigo operates a broad consumer self-care and nutrition platform, including infant formula (store brands) and specialty nutrition. Partial overlap with Nutricia's early-life nutrition and self-pay nutrition categories, though less focused on FSMP prescription channels.

Emerging players

  • Kate Farms: Kate Farms is a US-based plant-based enteral and oral medical nutrition company with formulas for pediatric and adult malnutrition. Overlaps with Nutricia's Fortimel PlantBased and Nutrison PlantBased 2kcal in the plant-based medical nutrition niche.

Regional players

  • HiPP: HiPP is a family-owned European leader in organic infant nutrition and complementary baby foods. Comparable to Nutricia's infant formula and first 1000 days portfolio, but primarily competes in European organic-leaning segments rather than FSMP medical nutrition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights7 records

Customer concentration

Nutricia social profiles

Digital presence

Nutricia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nutricia leadership team

Management profile

Number of profiles

Profiles4 records

Nutricia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nutricia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nutricia

What does Nutricia do?

Nutricia manufactures and sells specialized medical nutrition products classified as Foods for Special Medical Purposes (FSMP), including oral nutritional supplements (Fortimel), enteral/tube feeding formulas (Nutrison), preterm and allergy infant formulas (Nutrilon, Neocate, Aptamil Pepti), ketogenic formulas (Ketocal), inherited metabolic disorder products (Anamix, Lophlex, Loprofin), and condition-specific nutrition for oncology, frailty, stroke/dysphagia, wound care, and early Alzheimer's. Products are prescribed by healthcare professionals and dispensed through hospitals, clinics, and pharmacies across more than 100 countries.

Is Nutricia a public or private company?

Nutricia is a private company. It is classified as corporate owned and is currently operating.

When was Nutricia founded?

Nutricia was founded in 1896. It employs 5,001 to 10,000 people.

Where is Nutricia based?

Nutricia is headquartered in Hoofddorp, Netherlands, in the Europe region.

How does Nutricia make money?

Two revenue lines are on record. Specialized Medical Nutrition Products are the primary driver. The others are infant Nutrition Products.

Who are Nutricia's main competitors?

Direct peers on record are Abbott Nutrition, Nestlé Health Science, Fresenius Kabi, Mead Johnson Nutrition (Reckitt), Baxter International and Hero Group. Broad incumbents are Danone and Perrigo Company. Kate Farms is listed as an emerging player. HiPP is listed as a regional player.

Does Nutricia have an API?

No public API is recorded for Nutricia.

What industry is Nutricia in?

Nutricia's product category is Medical Nutrition. Its primary akta.pro industry code is AFAKAJAC, Medical Foods Manufacturing (Disease-Specific, Clinically Supervised), with a secondary code of CRADAEAO, Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mexico Business NewsStrategic Innovation Drives Growth in Latin AmericaEurofarma is expanding its pharmaceutical presence in Mexico, leveraging regional production facilities and a commercial workforce of over 340 employees to achieve annual growth rates between 10% and 15%. The company is actively pursuing regulatory approval for the epilepsy treatment Cenobamate and has established a partnership with Nutricia to enter the specialized medical nutrition segment. This strategic expansion aims to address unmet patient needs and strengthen Eurofarma's position as a leading multinational healthcare provider in Latin America.BusinesskoreaNutricia Aptaclub holds 'Selective Dining' for expectant mothers in BusanNutricia, a brand under the Danone Group, is hosting a 'Selective Dining' event in Busan from August 29 to September 13 for expectant mothers through its Aptaclub membership program. The event features customized French courses developed with restaurant Ramsey, incorporating Nutricia's nutritional expertise and local ingredients. This follows successful previous events in Seoul, with 240 teams selected via lottery to participate.PrtimesPKU Market Poised for 8.1% CAGR Through 2032 – PR TimesPW Consulting released a strategic preview of the phenylketonuria (PKU) market, projecting total market revenue to grow from approximately USD 640 million in 2025 to USD 1.09 billion by 2032, representing an 8.1% compound annual growth rate. The report identifies a concentrated competitive landscape with the top three and five players dominating market share, and highlights five key companies—BioMarin Pharmaceutical, PTC Therapeutics, Nestlé Health Science, Nutricia (Danone), and Otsuka Pharmaceutical—as the primary competitive forces shaping the market. The preview emphasizes that 2026 represents an inflection period for multiple late-stage assets, label extensions, and pivotal Phase 3 readouts that will reshape prescribing algorithms and payer reimbursement strategies.World food companyNutricia: Pioneering nutrition for every stage of lifeThis is a corporate brand overview page for Nutricia, a specialist nutrition company owned by Danone, detailing its history of over 125 years in early life and medical nutrition. The company operates the Nutricia Homeward Service supporting over 32,000 patients at home across the UK with tube feeding and medical deliveries, while its Liverpool facility serves patients across the UK, Ireland, and nearly 100 countries worldwide. Nutricia also outlined its environmental commitments including achieving net zero carbon by 2050 and 100% reusable, recyclable, or compostable packaging by 2025.World food companyNutriciaThe article describes Nutricia's focus on science-based nutritional solutions designed to promote health across all ages, from infancy to old age. It emphasizes the company's commitment to providing tailored support during critical life stages and its long history of contribution to maternal and child health.The Times of IndiaSaudi Arabia, Kuwait urgently recall baby formula products: What every consumer must knowSaudi Arabia and Kuwait have initiated a recall of baby formula products produced by Nutricia-Danone, including brands Aptamil and Bebelac, due to potential contamination with Cereulide produced by Bacillus cereus bacteria. The recall was prompted by voluntary notifications from the company and assessments by health authorities; no illnesses have been reported thus far.GulfNewsSaudi Arabia warns over infant formula recallThe Saudi Food and Drug Authority issued a public warning over infant milk products manufactured by Nutricia Danone under the Bebelac and Aptamil brands, following a voluntary precautionary recall of selected batches due to potential cereulide toxin contamination. The toxin, produced by Bacillus cereus bacteria, could pose health risks to infants with symptoms including nausea, vomiting, and abdominal pain appearing between 30 minutes and six hours after consumption, though no illnesses have been reported in Saudi Arabia to date. The regulator is coordinating with the manufacturer to withdraw the affected products from the market and is closely monitoring implementation of the recall.FortunebusinessinsightsOncology Nutrition Market Size, ShareThe global oncology nutrition market was valued at USD 2.87 billion in 2025 and is projected to grow significantly by 2034, driven by increasing cancer prevalence and advancements in treatment. Major companies like Abbott, Nestlé Health Science, Nutricia, and Fresenius Kabi AG are actively investing in new product development and strategic acquisitions. The market growth is also supported by rising awareness, new product launches, and regional development in North America, Europe, and Asia Pacific.Global Market Insights Inc.Enteral Nutrition Ingredients Market SizeGlobal Market Insights Inc. published a market research report on the enteral nutrition ingredients market, valued at USD 4.31 billion in 2025 and projected to reach USD 8.58 billion by 2035, growing at a 7.3% CAGR. The market is driven by rising chronic disease prevalence, aging populations, and expansion of home-based enteral care, with North America leading at USD 1.79 billion in 2025. Key players including Abbott, Nestlé Health Science, Nutricia (Danone), Fresenius Kabi, and Meiji collectively held approximately 55% market share in 2025.NutriciaNutricia’s new savory plant-based medical nutrition proven to improve patient adherenceNutricia, part of Danone, has launched Fortimel PlantBased Protein, its first savory-flavored plant-based medical nutrition drink, designed to support patients with disease-related malnutrition. A clinical study showed 95% of patients adhered to their prescription with the new product, compared to 20% who typically stop using medical nutrition due to flavor fatigue. The innovation, which has a 45% lower carbon footprint than standard alternatives, has been rolled out across over 10 markets including Spain, France, the Netherlands, Germany, Denmark, Norway, and Finland.